STX
52
-4
BMY
61
-3
AVGO
35
-2
CI
52
-7
VNO
60
8
NWSA
71
-2
GPC
40
2
UNH
63
-2
CF
53
2
AIG
47
6
WDC
38
-3
NRG
50
-2
RRC
60
-3
GILD
56
-4
MLM
57
-3
SYF
93
-2
PFG
50
-2
LEN
52
2
GLW
48
-5
OMC
64
-2
STX
52
-4
BMY
61
-3
AVGO
35
-2
CI
52
-7
VNO
60
8
NWSA
71
-2
GPC
40
2
UNH
63
-2
CF
53
2
AIG
47
6
WDC
38
-3
NRG
50
-2
RRC
60
-3
GILD
56
-4
MLM
57
-3
SYF
93
-2
PFG
50
-2
LEN
52
2
GLW
48
-5
OMC
64
-2
Financhill
Back

Intellia Therapeutics Quote, Financials, Valuation and Earnings

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
29

NTLA
Intellia Therapeutics

Last Price:
15.12
Seasonality Move:
12.78%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Intellia Therapeutics Price Quote

$15.12
-0.99 (-6.15%)
(Updated: November 14, 2024 at 4:55 PM ET)

Intellia Therapeutics Key Stats

Sell
29
Intellia Therapeutics (NTLA) is a Sell
Day range:
$16.10 - $17.30
52-week range:
$13.95 - $34.87
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
37.09
P/B ratio:
1.76%
Volume:
2.1M
Avg. volume:
2.6M
1-year change:
-32.34%
Market cap:
$1.7B
Revenue:
$36.3M
EPS:
$-5.44

How Much Does Intellia Therapeutics Make?

Is Intellia Therapeutics Growing As A Company?

  • What Is Intellia Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.24%
  • What Is Intellia Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Intellia Therapeutics Stock Price Performance

What Is Intellia Therapeutics 52-Week High & Low?

Intellia Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Intellia Therapeutics?

Is Intellia Therapeutics Cash Flow Positive?

  • What Is NTLA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$356.7M
  • What Is Intellia Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $289.9M
  • What Is Intellia Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $19.9M

Intellia Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    NTLA return on invested capital is -51.64%
  • What Is Intellia Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -42.33%
  • What Is NTLA Return On Equity?
    ROE is a measure of profitability and is -51.64%

Intellia Therapeutics Earnings Date & Stock Price

Intellia Therapeutics Competitors

Intellia Therapeutics Dividend Yield

Intellia Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 2.13%
Revenue: -24.02% 21.5%

Analyst Recommendations

Buy Recommendations: 18
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 59.82
Upside from Last Price: 271.3%

Major Shareholders

  • How many NTLA shares are owned by institutional investors?
    129.8M NTLA shares are owned by institutional investors
  • How many NTLA shares are owned by insiders?
    3M NTLA shares are owned by insiders